Program Description
Atopic dermatitis (eczema) is an inflammatory skin disorder that stems from a mutation in filaggrin protein that is expressed as a ceramide deficiency. In addition to this genetic factor, several environmental interactions have been shown to contribute to development of atopic dermatitis and contribute to disease flare-ups. This complex combination of factors causes patients with atopic dermatitis to experience a weakened skin barrier presenting as itchy, red, or scaly patches of skin. Pharmacists and pharmacy technicians need to understand the importance of ceramide-containing moisturizers in improving skin quality and overall health of patients with atopic dermatitis. As part of the skin care and ceramides curriculum, this webinar will further prepare pharmacists and pharmacy technicians to educate patients with atopic dermatitis about recommended products to improve skin hydration and barrier function.
Target audience: Retail pharmacists and specialty pharmacists
Type of activity: Application
Release date: January 31, 2022
Expiration date: January 31, 2023
Time to complete activity: 1 Hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Determine the pathophysiology, clinical burden, and impact of eczema on patient quality of life
- Investigate treatment and literature regarding eczema and the role of over-the-counter (OTC) products with ceramides and prebiotics/probiotics for the treatment and prevention of eczema
- Analyze the role of the pharmacist in guiding and educating patients about available OTC dermatologic products for the treatment and management of eczema and in making recommendations to prevent flare-ups
Aderonke Adeboye, PharmD, BCPS
Clinical Pharmacy Specialist
Dermatology
Emory University Hospital Midtown
Atlanta, Georgia
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-023-H01-P. The activity is available for CE credit through January 31, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Aderonke Adeboye, PharmD, BCPS, has the following relevant financial relationship to disclose:
Stock/shareholder: Incyte Pharmaceuticals
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
